Table 5.
Percentage representation of gasometric parameters of adult pigs, which received a combination of azaperone (3 mg kg−1), midazolam (0.3 mg kg−1), and ketamine (7 mg kg−1), via intramuscular (GIM, n = 8) and intranasal (GIN, n = 8) routes.
| Variable | Time | GIN (% of animals) | GIM (% de animais) | Reference | ||||
|---|---|---|---|---|---|---|---|---|
| Below | Normal | Above | Below | Normal | Above | (unit) | ||
| 0 | 40 | 60 | 0 | 33 | 67 | a35–44 (mmHg) | ||
| T20 | 0 | 50 | 50 | 0 | 43 | 57 | ||
| T30 | 0 | 67 | 33 | 0 | 29 | 71 | ||
| T45 | 0 | 38 | 63 | 0 | 29 | 71 | ||
| T60 | 14 | 43 | 43 | 0 | 43 | 57 | ||
| T90 | 20 | 60 | 20 | 0 | 50 | 50 | ||
| Mean | 5 | 50 | 45 | 0 | 38 | 62 | ||
| 33 | 67 | 0 | 50 | 50 | 0 | b82–108 (mmHg) | ||
| T20 | 25 | 75 | 0 | 67 | 33 | 0 | ||
| T30 | 0 | 75 | 25 | 33 | 67 | 0 | ||
| T45 | 0 | 100 | 0 | 67 | 33 | 0 | ||
| T60 | 0 | 100 | 0 | 33 | 67 | 0 | ||
| T90 | 0 | 100 | 0 | 33 | 33 | 33 | ||
| Mean | 11 | 83 | 6 | 47 | 47 | 6 | ||
| BE | 40 | 60 | 0 | 33 | 67 | 0 | c4.6–12.6 (mMol L−1) | |
| T20 | 38 | 63 | 0 | 43 | 57 | 0 | ||
| T30 | 33 | 67 | 0 | 43 | 57 | 0 | ||
| T45 | 38 | 63 | 0 | 43 | 57 | 0 | ||
| T60 | 43 | 57 | 0 | 43 | 57 | 0 | ||
| T90 | 40 | 60 | 0 | 33 | 67 | 0 | ||
| Mean | 38 | 62 | 0 | 41 | 59 | 0 | ||
| K+ | 100 | 0 | 0 | 67 | 33 | 0 | d3.9–7.8 (mMol L−1) | |
| T20 | 88 | 13 | 0 | 71 | 29 | 0 | ||
| T30 | 89 | 11 | 0 | 100 | 0 | 0 | ||
| T45 | 75 | 25 | 0 | 71 | 29 | 0 | ||
| T60 | 71 | 29 | 0 | 71 | 29 | 0 | ||
| T90 | 100 | 0 | 0 | 67 | 33 | 0 | ||
| Mean | 86 | 14 | 0 | 76 | 24 | 0 | ||
| Ca2+ | 100 | 0 | 0 | 100 | 0 | 0 | e2.25–3.1 (mMol L−1) | |
| T20 | 100 | 0 | 0 | 100 | 0 | 0 | ||
| T30 | 100 | 0 | 0 | 100 | 0 | 0 | ||
| T45 | 100 | 0 | 0 | 100 | 0 | 0 | ||
| T60 | 100 | 0 | 0 | 100 | 0 | 0 | ||
| T90 | 100 | 0 | 0 | 100 | 0 | 0 | ||
| Mean | 100 | 0 | 0 | 100 | 0 | 0 | ||
| Glic | 0 | 100 | 0 | 0 | 100 | 0 | f2.6–8.6 (mMol L−1) | |
| T20 | 0 | 100 | 0 | 0 | 100 | 0 | ||
| T30 | 0 | 100 | 0 | 0 | 86 | 14 | ||
| T45 | 0 | 100 | 0 | 0 | 86 | 14 | ||
| T60 | 0 | 100 | 0 | 0 | 86 | 14 | ||
| T90 | 0 | 100 | 0 | 0 | 100 | 0 | ||
| Mean | 0 | 100 | 0 | 0 | 92 | 8 | ||
| Lac | 0 | 20 | 80 | 0 | 33 | 67 | g0.5–1.5 (mMol L−1) | |
| T20 | 0 | 25 | 75 | 0 | 0 | 100 | ||
| T30 | 0 | 22 | 78 | 0 | 29 | 71 | ||
| T45 | 0 | 13 | 88 | 0 | 29 | 71 | ||
| T60 | 0 | 43 | 57 | 0 | 29 | 71 | ||
| T90 | 0 | 0 | 100 | 0 | 33 | 67 | ||
| Mean | 0 | 21 | 79 | 0 | 24 | 76 | ||
| pHst | -T90 | 0 | 100 | 0 | 0 | 100 | 0 | h7.4–7.54 |
| -T90 | 0 | 100 | 0 | 0 | 100 | 0 | i22–36.6 (mMol L−1) | |
| Na+ | -T90 | 0 | 100 | 0 | 0 | 100 | 0 | j129–156 (mMol L−1) |
| Cl− | -T90 | 0 | 100 | 0 | 0 | 100 | 0 | k93–126 (mMol L−1) |
a: 35–44 mmHg (36); 36–44 mmHg (35). b: 82–102 mmHg (35). cBE: 4.6–12.6 mMol L−1 (35); 7.5–mMol L−1 (37). dK+: 3.9–4.1 mMol L−1 (36); 4.8–7.8 mMol L−1 (38). eCa2+: 2.25–2.8 mMol L−1 (36); 2.5–3.1 mMol L−1 (38). fGlic: 2.6–6.5 mMol L−1 (36); 4.3–8.6 mMol L−1 (38). gLac: 0.5–8.5 mMol L−1 (36); 2.8–3.1 mMol L−1 (37); hpHst: 7.4–7.53 (36); 7.45–7.54 (35). i: 22–33 mMol L−1 (36); 27.8–36.6 mMol L−1 (35). jNa+: 129–143 mMol/L (36); 143–156 mMol L−1 (38). k Cl−: 93–126 mMol L−1 (36); 99.5–112.3 mMol L−1 (38). *Minutes after AMK administration. Trec: Trecumbency.